Novel immune checkpoint inhibitor strategies in advanced non-small cell lung cancer: towards biomarker-driven therapies?

Benthe B. Muntinghe-Wagenaar, T. Jeroen N. Hiltermann*

*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

53 Downloads (Pure)

Search results